rs1555899735
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PS1_ModeratePP3PM2_SupportingPS3_ModeratePM1_Supporting
This summary comes from the ClinGen Evidence Repository: NM_001754.5(RUNX1):c.316T>C (p.Trp106Arg) is found within the runt homology domain (RHD) in a residue which is not an established hotspot (PM1_supporting). The c.316T>C variant is the same amino acid change (p.Trp106Arg) as a previously established likely pathogenic variant (ClinVar ID 436617) curated using MM-VCEP rules for RUNX1 (PS1_Moderate). This missense variant has a REVEL score ≥ 0.88 (0.976) (PP3) and transactivation assays demonstrating altered transactivation (<20% of wt, and/or reduced to levels similar to well-established pathogenic variants such as R201Q or R166Q)(PS3_moderate, PMID:25840971). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_Supporting). In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PS1_moderate, PS3_moderate, PP3, PM1_supporting, PM2_supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA410203507/MONDO:0011071/008
Frequency
Consequence
NM_001754.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome Pathogenic:1
NM_001754.5(RUNX1):c.316T>C (p.Trp106Arg) is found within the runt homology domain (RHD) in a residue which is not an established hotspot (PM1_supporting). The c.316T>C variant is the same amino acid change (p.Trp106Arg) as a previously established likely pathogenic variant (ClinVar ID 436617) curated using MM-VCEP rules for RUNX1 (PS1_Moderate). This missense variant has a REVEL score ≥ 0.88 (0.976) (PP3) and transactivation assays demonstrating altered transactivation (<20% of wt, and/or reduced to levels similar to well-established pathogenic variants such as R201Q or R166Q)(PS3_moderate, PMID: 25840971). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_Supporting). In summary, this variant meets criteria to be classified as likely pathogenic. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PS1_moderate, PS3_moderate, PP3, PM1_supporting, PM2_supporting. -
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on RUNX1 function (PMID: 25840971). This sequence change replaces tryptophan, which is neutral and slightly polar, with arginine, which is basic and polar, at codon 106 of the RUNX1 protein (p.Trp106Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with chronic myelomonocytic leukemia (PMID: 25840971). This variant is also known as 235T>C (p.Trp79Arg). ClinVar contains an entry for this variant (Variation ID: 1045299). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at